Donoghue Forlines LLC Jazz Pharmaceuticals PLC Transaction History

Donoghue Forlines LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	BUY	$122.5 - $147.16 $268,520 - $322,574	2,192 New	2,192 $271,000
Q4 2022 Feb 08, 2023	BUY	$129.72 - $159.85 $1.08 Million - $1.34 Million	8,356 Added 550.1%	9,875 $1.57 Million
Q3 2022 Nov 07, 2022	SELL	$126.59 - $161.18 $338,628 - $431,156	-2,675 Reduced 63.78%	1,519 $202,000
Q2 2022 Aug 08, 2022	BUY	$141.59 - $168.66 $593,828 - $707,360	4,194 New	4,194 $654,000
Q3 2021 Nov 15, 2021	SELL	$128.64 - $184.79 $487,802 - $700,723	-3,792 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$160.2 - $186.42 $3,684 - $4,287	-23 Reduced 0.6%	3,792 $674,000
Q1 2021 May 14, 2021	SELL	$150.19 - $173.5 $85,458 - $98,721	-569 Reduced 12.98%	3,815 $627,000
Q4 2020 Feb 09, 2021	BUY	$140.71 - $165.05 $616,872 - $723,579	4,384 New	4,384 $724,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Donoghue Forlines LLC, based on Form 13F filings with the SEC.

Stay updated on Donoghue Forlines LLC with notifications on news.